Korro Bio

Korro Bio Dividend Coverage

Dividend Coverage Ratio of Korro Bio (KRRO) as of Oct 17, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Korro Bio is 2026 - . Dividend Coverage Ratio of Korro Bio was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Korro Bio Stock analysis

What does Korro Bio do? Korro Bio Inc, headquartered in Cambridge, Massachusetts, operates in the Biotechnology sector within the Health Care industry. The company, listed on 3 October 2019, employs 58 full-time staff. Korro Bio develops genetic medicines using RNA editing technology, focusing on rare and prevalent diseases. Its OPERA platform enables precise, transient RNA edits without altering DNA, targeting the liver and central nervous system to modify protein function through natural cellular processes. Korro Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Korro Bio stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Korro Bio since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Korro Bio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Korro Bio

All Key Metrics — Korro Bio